Male Infertility Market Research Report by Test (Computer-assisted Semen Analysis, DNA Fragmentation Technique, Microscopic Examination, Oxidative Stress Analysis, and Sperm Agglutination), by Treatment (Assisted Reproductive Technology and Medication) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Male Infertility Market is expected to grow from USD 676.79 Million in 2020 to USD 1,778.20 Million by the end of 2025.
2. The Global Male Infertility Market is expected to grow from EUR 593.42 Million in 2020 to EUR 1,559.16 Million by the end of 2025.
3. The Global Male Infertility Market is expected to grow from GBP 527.55 Million in 2020 to GBP 1,386.10 Million by the end of 2025.
4. The Global Male Infertility Market is expected to grow from JPY 72,231.31 Million in 2020 to JPY 189,779.85 Million by the end of 2025.
5. The Global Male Infertility Market is expected to grow from AUD 982.79 Million in 2020 to AUD 2,582.19 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Male Infertility to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Test, the Male Infertility Market studied across Computer-assisted Semen Analysis, DNA Fragmentation Technique, Microscopic Examination, Oxidative Stress Analysis, Sperm Agglutination, and Sperm Penetration Assay.
Based on Treatment, the Male Infertility Market studied across Assisted Reproductive Technology and Medication.
Based on Geography, the Male Infertility Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Male Infertility Market including Andrology Solutions, Aytu BioScience, Inc., Bayer Group, Cadila Healthcare Ltd., EMD Sereno, Inc., Endo International Plc, Halotech DNA S.L, Intas Pharmaceuticals Ltd., Sanofi, and SCSA Diagnostics, Inc..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Male Infertility Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Male Infertility Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Male Infertility Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Male Infertility Market?
4. What is the competitive strategic window for opportunities in the Global Male Infertility Market?
5. What are the technology trends and regulatory frameworks in the Global Male Infertility Market?
6. What are the modes and strategic moves considered suitable for entering the Global Male Infertility Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Male Infertility Market is expected to grow from USD 676.79 Million in 2020 to USD 1,778.20 Million by the end of 2025.
2. The Global Male Infertility Market is expected to grow from EUR 593.42 Million in 2020 to EUR 1,559.16 Million by the end of 2025.
3. The Global Male Infertility Market is expected to grow from GBP 527.55 Million in 2020 to GBP 1,386.10 Million by the end of 2025.
4. The Global Male Infertility Market is expected to grow from JPY 72,231.31 Million in 2020 to JPY 189,779.85 Million by the end of 2025.
5. The Global Male Infertility Market is expected to grow from AUD 982.79 Million in 2020 to AUD 2,582.19 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Male Infertility to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Test, the Male Infertility Market studied across Computer-assisted Semen Analysis, DNA Fragmentation Technique, Microscopic Examination, Oxidative Stress Analysis, Sperm Agglutination, and Sperm Penetration Assay.
Based on Treatment, the Male Infertility Market studied across Assisted Reproductive Technology and Medication.
Based on Geography, the Male Infertility Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Male Infertility Market including Andrology Solutions, Aytu BioScience, Inc., Bayer Group, Cadila Healthcare Ltd., EMD Sereno, Inc., Endo International Plc, Halotech DNA S.L, Intas Pharmaceuticals Ltd., Sanofi, and SCSA Diagnostics, Inc..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Male Infertility Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Male Infertility Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Male Infertility Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Male Infertility Market?
4. What is the competitive strategic window for opportunities in the Global Male Infertility Market?
5. What are the technology trends and regulatory frameworks in the Global Male Infertility Market?
6. What are the modes and strategic moves considered suitable for entering the Global Male Infertility Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Test Outlook
3.4. Treatment Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL MALE INFERTILITY MARKET, BY TEST
6.1. Introduction
6.2. Computer-assisted Semen Analysis
6.3. DNA Fragmentation Technique
6.4. Microscopic Examination
6.5. Oxidative Stress Analysis
6.6. Sperm Agglutination
6.7. Sperm Penetration Assay
7. GLOBAL MALE INFERTILITY MARKET, BY TREATMENT
7.1. Introduction
7.2. Assisted Reproductive Technology
7.3. Medication
8. AMERICAS MALE INFERTILITY MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC MALE INFERTILITY MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. Andrology Solutions
12.2. Aytu BioScience, Inc.
12.3. Bayer Group
12.4. Cadila Healthcare Ltd.
12.5. EMD Sereno, Inc.
12.6. Endo International Plc
12.7. Halotech DNA S.L
12.8. Intas Pharmaceuticals Ltd.
12.9. Sanofi
12.10. SCSA Diagnostics, Inc.
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Test Outlook
3.4. Treatment Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL MALE INFERTILITY MARKET, BY TEST
6.1. Introduction
6.2. Computer-assisted Semen Analysis
6.3. DNA Fragmentation Technique
6.4. Microscopic Examination
6.5. Oxidative Stress Analysis
6.6. Sperm Agglutination
6.7. Sperm Penetration Assay
7. GLOBAL MALE INFERTILITY MARKET, BY TREATMENT
7.1. Introduction
7.2. Assisted Reproductive Technology
7.3. Medication
8. AMERICAS MALE INFERTILITY MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC MALE INFERTILITY MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. Andrology Solutions
12.2. Aytu BioScience, Inc.
12.3. Bayer Group
12.4. Cadila Healthcare Ltd.
12.5. EMD Sereno, Inc.
12.6. Endo International Plc
12.7. Halotech DNA S.L
12.8. Intas Pharmaceuticals Ltd.
12.9. Sanofi
12.10. SCSA Diagnostics, Inc.
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL MALE INFERTILITY MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL MALE INFERTILITY MARKET SIZE, BY COMPUTER-ASSISTED SEMEN ANALYSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL MALE INFERTILITY MARKET SIZE, BY DNA FRAGMENTATION TECHNIQUE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL MALE INFERTILITY MARKET SIZE, BY MICROSCOPIC EXAMINATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL MALE INFERTILITY MARKET SIZE, BY OXIDATIVE STRESS ANALYSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL MALE INFERTILITY MARKET SIZE, BY SPERM AGGLUTINATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL MALE INFERTILITY MARKET SIZE, BY SPERM PENETRATION ASSAY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL MALE INFERTILITY MARKET SIZE, BY MEDICATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. AMERICAS MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. AMERICAS MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. AMERICAS MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. ARGENTINA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. ARGENTINA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. BRAZIL MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. BRAZIL MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. CANADA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. CANADA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. MEXICO MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. MEXICO MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. UNITED STATES MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. UNITED STATES MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. AUSTRALIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. AUSTRALIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. CHINA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. CHINA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. INDIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. INDIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. INDONESIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. INDONESIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. JAPAN MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. JAPAN MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. MALAYSIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. MALAYSIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. PHILIPPINES MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. PHILIPPINES MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. SOUTH KOREA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. SOUTH KOREA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. THAILAND MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. THAILAND MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. FRANCE MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. FRANCE MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. GERMANY MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. GERMANY MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. ITALY MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. ITALY MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. NETHERLANDS MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. NETHERLANDS MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. QATAR MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. QATAR MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. RUSSIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. RUSSIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SAUDI ARABIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SAUDI ARABIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SOUTH AFRICA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. SOUTH AFRICA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SPAIN MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SPAIN MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. UNITED ARAB EMIRATES MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. UNITED ARAB EMIRATES MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. GLOBAL MALE INFERTILITY MARKET: SCORES
TABLE 74. GLOBAL MALE INFERTILITY MARKET: BUSINESS STRATEGY
TABLE 75. GLOBAL MALE INFERTILITY MARKET: PRODUCT SATISFACTION
TABLE 76. GLOBAL MALE INFERTILITY MARKET: RANKING
TABLE 77. GLOBAL MALE INFERTILITY MARKET: MERGER & ACQUISITION
TABLE 78. GLOBAL MALE INFERTILITY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 79. GLOBAL MALE INFERTILITY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 80. GLOBAL MALE INFERTILITY MARKET: INVESTMENT & FUNDING
TABLE 81. GLOBAL MALE INFERTILITY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 82. GLOBAL MALE INFERTILITY MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL MALE INFERTILITY MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL MALE INFERTILITY MARKET SIZE, BY COMPUTER-ASSISTED SEMEN ANALYSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL MALE INFERTILITY MARKET SIZE, BY DNA FRAGMENTATION TECHNIQUE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL MALE INFERTILITY MARKET SIZE, BY MICROSCOPIC EXAMINATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL MALE INFERTILITY MARKET SIZE, BY OXIDATIVE STRESS ANALYSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL MALE INFERTILITY MARKET SIZE, BY SPERM AGGLUTINATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL MALE INFERTILITY MARKET SIZE, BY SPERM PENETRATION ASSAY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL MALE INFERTILITY MARKET SIZE, BY MEDICATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. AMERICAS MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. AMERICAS MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. AMERICAS MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. ARGENTINA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. ARGENTINA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. BRAZIL MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. BRAZIL MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. CANADA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. CANADA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. MEXICO MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. MEXICO MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. UNITED STATES MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. UNITED STATES MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. AUSTRALIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. AUSTRALIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. CHINA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. CHINA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. INDIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. INDIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. INDONESIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. INDONESIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. JAPAN MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. JAPAN MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. MALAYSIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. MALAYSIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. PHILIPPINES MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. PHILIPPINES MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. SOUTH KOREA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. SOUTH KOREA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. THAILAND MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. THAILAND MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. FRANCE MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. FRANCE MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. GERMANY MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. GERMANY MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. ITALY MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. ITALY MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. NETHERLANDS MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. NETHERLANDS MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. QATAR MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. QATAR MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. RUSSIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. RUSSIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SAUDI ARABIA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SAUDI ARABIA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SOUTH AFRICA MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. SOUTH AFRICA MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SPAIN MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SPAIN MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. UNITED ARAB EMIRATES MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. UNITED ARAB EMIRATES MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY TEST, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. GLOBAL MALE INFERTILITY MARKET: SCORES
TABLE 74. GLOBAL MALE INFERTILITY MARKET: BUSINESS STRATEGY
TABLE 75. GLOBAL MALE INFERTILITY MARKET: PRODUCT SATISFACTION
TABLE 76. GLOBAL MALE INFERTILITY MARKET: RANKING
TABLE 77. GLOBAL MALE INFERTILITY MARKET: MERGER & ACQUISITION
TABLE 78. GLOBAL MALE INFERTILITY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 79. GLOBAL MALE INFERTILITY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 80. GLOBAL MALE INFERTILITY MARKET: INVESTMENT & FUNDING
TABLE 81. GLOBAL MALE INFERTILITY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 82. GLOBAL MALE INFERTILITY MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL MALE INFERTILITY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL MALE INFERTILITY MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL MALE INFERTILITY MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL MALE INFERTILITY MARKET SIZE, BY TEST, 2020 (USD MILLION)
FIGURE 5. GLOBAL MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2020 (USD MILLION)
FIGURE 6. GLOBAL MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL MALE INFERTILITY MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL MALE INFERTILITY MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL MALE INFERTILITY MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL MALE INFERTILITY MARKET SIZE, BY TEST, 2020 VS 2025 (%)
FIGURE 14. GLOBAL MALE INFERTILITY MARKET SIZE, BY TEST, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MALE INFERTILITY MARKET SIZE, BY TEST, 2025
FIGURE 16. GLOBAL MALE INFERTILITY MARKET SIZE, BY COMPUTER-ASSISTED SEMEN ANALYSIS, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL MALE INFERTILITY MARKET SIZE, BY DNA FRAGMENTATION TECHNIQUE, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL MALE INFERTILITY MARKET SIZE, BY MICROSCOPIC EXAMINATION, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL MALE INFERTILITY MARKET SIZE, BY OXIDATIVE STRESS ANALYSIS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL MALE INFERTILITY MARKET SIZE, BY SPERM AGGLUTINATION, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL MALE INFERTILITY MARKET SIZE, BY SPERM PENETRATION ASSAY, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2020 VS 2025 (%)
FIGURE 23. GLOBAL MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2020 VS 2025 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2025
FIGURE 25. GLOBAL MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL MALE INFERTILITY MARKET SIZE, BY MEDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 27. AMERICAS MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 28. AMERICAS MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 30. ARGENTINA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. BRAZIL MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. CANADA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. MEXICO MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. UNITED STATES MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 36. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 38. AUSTRALIA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. CHINA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. INDIA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. INDONESIA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. JAPAN MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. MALAYSIA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. PHILIPPINES MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. SOUTH KOREA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. THAILAND MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 48. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 50. FRANCE MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. GERMANY MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. ITALY MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. NETHERLANDS MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. QATAR MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. RUSSIA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. SAUDI ARABIA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. SOUTH AFRICA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. SPAIN MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. UNITED ARAB EMIRATES MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. GLOBAL MALE INFERTILITY MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 62. GLOBAL MALE INFERTILITY MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 63. GLOBAL MALE INFERTILITY MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 64. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL MALE INFERTILITY MARKET, BY TYPE
FIGURE 1. GLOBAL MALE INFERTILITY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL MALE INFERTILITY MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL MALE INFERTILITY MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL MALE INFERTILITY MARKET SIZE, BY TEST, 2020 (USD MILLION)
FIGURE 5. GLOBAL MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2020 (USD MILLION)
FIGURE 6. GLOBAL MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL MALE INFERTILITY MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL MALE INFERTILITY MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL MALE INFERTILITY MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL MALE INFERTILITY MARKET SIZE, BY TEST, 2020 VS 2025 (%)
FIGURE 14. GLOBAL MALE INFERTILITY MARKET SIZE, BY TEST, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MALE INFERTILITY MARKET SIZE, BY TEST, 2025
FIGURE 16. GLOBAL MALE INFERTILITY MARKET SIZE, BY COMPUTER-ASSISTED SEMEN ANALYSIS, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL MALE INFERTILITY MARKET SIZE, BY DNA FRAGMENTATION TECHNIQUE, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL MALE INFERTILITY MARKET SIZE, BY MICROSCOPIC EXAMINATION, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL MALE INFERTILITY MARKET SIZE, BY OXIDATIVE STRESS ANALYSIS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL MALE INFERTILITY MARKET SIZE, BY SPERM AGGLUTINATION, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL MALE INFERTILITY MARKET SIZE, BY SPERM PENETRATION ASSAY, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2020 VS 2025 (%)
FIGURE 23. GLOBAL MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2020 VS 2025 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL MALE INFERTILITY MARKET SIZE, BY TREATMENT, 2025
FIGURE 25. GLOBAL MALE INFERTILITY MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL MALE INFERTILITY MARKET SIZE, BY MEDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 27. AMERICAS MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 28. AMERICAS MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 30. ARGENTINA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. BRAZIL MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. CANADA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. MEXICO MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. UNITED STATES MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 36. ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 38. AUSTRALIA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. CHINA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. INDIA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. INDONESIA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. JAPAN MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. MALAYSIA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. PHILIPPINES MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. SOUTH KOREA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. THAILAND MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 48. EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 50. FRANCE MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. GERMANY MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. ITALY MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. NETHERLANDS MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. QATAR MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. RUSSIA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. SAUDI ARABIA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. SOUTH AFRICA MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. SPAIN MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. UNITED ARAB EMIRATES MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. UNITED KINGDOM MALE INFERTILITY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. GLOBAL MALE INFERTILITY MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 62. GLOBAL MALE INFERTILITY MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 63. GLOBAL MALE INFERTILITY MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 64. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL MALE INFERTILITY MARKET, BY TYPE
